A group of nine plaintiffs from several different states have come together to jointly file a lawsuit against the blood-thinning drug Xarelto.

The plaintiffs claim Xarelto side effects cause them serious injuries or the death of family member.

Xarelto Dangers and Risks

Xarelto was approved in July 2011 for the treatment and prevention of blood clots in patients going through hip and knee replacement surgery and for the prevention of stroke in patients with atrial fibrillation and for the prevention of deep vein thrombosis.

Xarelto is the first of a new generation of anticoagulant medications that have been advertised as being superior to warfarin, a drug that has been in use for 60 years.

People taking warfarin must have regular blood monitoring and the drug carries dietary restrictions; Xarelto does not. But there is no known antidote for Xarelto complications such as internal bleeding, while there is an antidote for warfarin.

The lack of an antidote is a serious concern: when a patient taking Xarelto experiences excessive bleeding, the person simply has to wait for the drug to clears from the system, which can make a bleeding episode dangerous and possibly even deadly.

Reported adverse Xarelto side effects Include

• Brain hemorrhage
• Gastrointestinal bleeding
• Uncontrollable Internal Bleeding

These Xarelto complications can result in emergency hospital visits, extended hospital care for ongoing treatments, and in extreme cases, death.

Xarelto Side Effects Caused Injury, Death

Plaintiff Annie Edwards of Alabama, claims she ingested Xarelto for less than one month before she suffered severe bleeding for which she was hospitalized in April 2015.

Another plaintiff, Donnie P., who is being represented by his surviving wife Marion, died from alleged Xarelto complications in July 2014.  He was prescribed Xarelto in March 2014.

The other named plaintiffs in the Xarelto lawsuit all assert similar claims that Xarelto side effects caused them to suffer life-threatening internal bleeding which required emergency medical intervention.

The charges in this Xarelto lawsuit include wrongful death, strict product liability, negligent misrepresentation, and fraud.

The plaintiffs are seeking compensatory, economic, punitive, and exemplary damages for Janssen’s alleged disregard and reckless indifference for the safety and welfare of the general public by failing to warn of dangerous Xarelto side effects.

Xarelto Litigation

Meanwhile, Xarelto lawsuits have been piling up, with plaintiffs claiming injuries and even death from the drug.

These cases form two major groupings: more than 2,800 federal lawsuits have been consolidated into a multidistrict litigation (MDL) Eastern Louisiana, while another 620 cases form a mass tort program in the Court of Common Pleas in Philadelphia, Pennsylvania.

According to these lawsuits, without a Xarelto antidote, doctors have no effective means of stopping a patients from bleeding in the event of an emergency.

The lawsuits also claim that patients and doctors should have been better warned about Xarelto side effects and risks and are now seeking compensation from the drug maker for medical bills, funeral expenses and other losses.

The Xarelto Lawsuit is filed within the larger consolidated multidistrict litigation In Re: Xarelto Products Liability Litigation, MDL No. 2592, in the U.S. District Court for the Eastern District of Louisiana.